Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:32 am Sale | 2024-11-08 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 11,121,651 10.525% | -336,043 (-2.93%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | BlackRock Inc. BLK | 6,218,671 5.900% | 0 (Unchanged) | Filing History |
| 2024-10-24 2:02 pm Sale | 2024-09-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | BlackRock Inc. BLK | 6,218,671 5.900% | -1,974,316 (-24.10%) | Filing History |
| 2024-10-10 12:36 pm Purchase | 2024-09-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | JPMORGAN CHASE & CO JPM | 5,296,395 5.000% | 5,296,395 (New Position) | Filing History |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | Intra-Cellular Therapies, Inc. ITCI | The Vanguard Group | 9,094,302 9.450% | 775,053 (+9.32%) | Filing History |
| 2024-02-09 12:40 pm Sale | 2024-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 3,627,308 3.800% | -1,112,837 (-23.48%) | Filing History |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 11,457,694 11.905% | -571,095 (-4.75%) | Filing History |
| 2024-02-08 10:14 am Sale | 2023-12-29 | 13G | Intra-Cellular Therapies, Inc. ITCI | Wellington Management Group LLP | 1,763,475 1.830% | -3,646,210 (-67.40%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | BlackRock Inc. BLK | 8,192,987 8.500% | 743,458 (+9.98%) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | The Vanguard Group | 8,319,249 8.780% | 1,443,048 (+20.99%) | Filing History |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 12,028,789 12.701% | 1,066,820 (+9.73%) | Filing History |
| 2023-02-06 2:53 pm Purchase | 2022-12-30 | 13G | Intra-Cellular Therapies, Inc. ITCI | Wellington Management Group LLP | 5,409,685 5.710% | 5,409,685 (New Position) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | BlackRock Inc. BLK | 7,449,529 7.900% | 1,727,763 (+30.20%) | Filing History |
| 2023-01-10 2:38 pm Sale | 2023-01-10 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 4,740,145 5.010% | -3,495,623 (-42.44%) | Filing History |
| 2022-02-10 1:38 pm Sale | 2022-02-10 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 8,235,768 10.100% | -83,444 (-1.00%) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | The Vanguard Group | 6,876,201 8.440% | 394,857 (+6.09%) | Filing History |
| 2022-02-09 09:19 am Sale | 2022-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI | FMR LLC | 10,961,969 13.456% | -1,061,615 (-8.83%) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | BlackRock Inc. BLK | 5,721,766 7.000% | -176,802 (-3.00%) | Filing History |
| 2021-12-02 11:31 am Purchase | 2021-12-02 | 13G | Intra-Cellular Therapies, Inc. ITCI | WASATCH ADVISORS LP | 8,319,212 10.200% | 1,985,312 (+31.34%) | Filing History |
| 2021-02-12 5:18 pm Purchase | 2020-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI | BB Biotech AG | 3,538,419 4.400% | 80,000 (+2.31%) | Filing History |